Aggarwal C - Search Results

1

Outcomes in patients treated with frontline immune checkpoint inhibition (ICI) for advanced NSCLC with KRAS mutations and STK11/KEAP1 comutations across PD-L1 levels.

Sun L, Handorf EA, Zhou Y, Borghaei H, Aggarwal C, Bauman J. Sun L, et al. Among authors: aggarwal c. Lung Cancer. 2024 Apr;190:107510. doi: 10.1016/j.lungcan.2024.107510. Epub 2024 Feb 24. Lung Cancer. 2024. PMID: 38432028

2

Rational use of cetuximab in the treatment of advanced non-small cell lung cancer.

Aggarwal C, Borghaei H. Aggarwal C, et al. Onco Targets Ther. 2009 Feb 18;2:251-60. doi: 10.2147/ott.s4761. Onco Targets Ther. 2009. PMID: 20616912 Free PMC article.

3

Frequency of EGFR and KRAS mutations in patients with non small cell lung cancer by racial background: do disparities exist?

Bauml J, Mick R, Zhang Y, Watt CD, Vachani A, Aggarwal C, Evans T, Langer C. Bauml J, et al. Among authors: aggarwal c. Lung Cancer. 2013 Sep;81(3):347-353. doi: 10.1016/j.lungcan.2013.05.011. Epub 2013 Jun 24. Lung Cancer. 2013. PMID: 23806795 Free PMC article.

4

Multidisciplinary therapy of stage IIIA non-small-cell lung cancer: long-term outcome of chemoradiation with or without surgery.

Aggarwal C, Li L, Borghaei H, Mehra R, Somaiah N, Turaka A, Langer CJ, Simon GR. Aggarwal C, et al. Cancer Control. 2014 Jan;21(1):57-62. doi: 10.1177/107327481402100108. Cancer Control. 2014. PMID: 24357742 Free article.

5

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer.

Bagley SJ, Kothari S, Aggarwal C, Bauml JM, Alley EW, Evans TL, Kosteva JA, Ciunci CA, Gabriel PE, Thompson JC, Stonehouse-Lee S, Sherry VE, Gilbert E, Eaby-Sandy B, Mutale F, DiLullo G, Cohen RB, Vachani A, Langer CJ. Bagley SJ, et al. Among authors: aggarwal c. Lung Cancer. 2017 Apr;106:1-7. doi: 10.1016/j.lungcan.2017.01.013. Epub 2017 Jan 25. Lung Cancer. 2017. PMID: 28285682

6

Treatment Paradigms for Advanced Non-Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design.

Aggarwal C, Borghaei H. Aggarwal C, et al. Oncologist. 2017 Jun;22(6):700-708. doi: 10.1634/theoncologist.2016-0345. Epub 2017 Apr 13. Oncologist. 2017. PMID: 28408617 Free PMC article. Review.

7

SWOG S1400D (NCT02965378), a Phase II Study of the Fibroblast Growth Factor Receptor Inhibitor AZD4547 in Previously Treated Patients With Fibroblast Growth Factor Pathway-Activated Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy).

Aggarwal C, Redman MW, Lara PN Jr, Borghaei H, Hoffman P, Bradley JD, Newman AJ 3rd, Feldman MJ, Minichiello K, Miao J, Mack PC, Papadimitrakopoulou VA, Herbst RS, Kelly K, Gandara DR. Aggarwal C, et al. J Thorac Oncol. 2019 Oct;14(10):1847-1852. doi: 10.1016/j.jtho.2019.05.041. Epub 2019 Jun 11. J Thorac Oncol. 2019. PMID: 31195180 Free PMC article. Clinical Trial.

8

Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer.

Beck TN, Boumber YA, Aggarwal C, Pei J, Thrash-Bingham C, Fittipaldi P, Vlasenkova R, Rao C, Borghaei H, Cristofanilli M, Mehra R, Serebriiskii I, Alpaugh RK. Beck TN, et al. Among authors: aggarwal c. BMC Cancer. 2019 Jun 19;19(1):603. doi: 10.1186/s12885-019-5795-x. BMC Cancer. 2019. PMID: 31215484 Free PMC article.

9

Impact of KRAS and TP53 Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With STK11-Mutated Advanced Non-Small-Cell Lung Cancer.

Bange E, Marmarelis ME, Hwang WT, Yang YX, Thompson JC, Rosenbaum J, Bauml JM, Ciunci C, Alley EW, Cohen RB, Langer CJ, Carpenter E, Aggarwal C. Bange E, et al. Among authors: aggarwal c. JCO Precis Oncol. 2019;3:PO.18.00326. doi: 10.1200/PO.18.00326. Epub 2019 May 10. JCO Precis Oncol. 2019. PMID: 31428721 Free PMC article.

10

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020.

Ettinger DS, Wood DE, Aggarwal C, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D'Amico TA, Dilling TJ, Dobelbower M, Gettinger S, Govindan R, Gubens MA, Hennon M, Horn L, Lackner RP, Lanuti M, Leal TA, Lin J, Loo BW Jr, Martins RG, Otterson GA, Patel SP, Reckamp KL, Riely GJ, Schild SE, Shapiro TA, Stevenson J, Swanson SJ, Tauer KW, Yang SC, Gregory K; OCN; Hughes M. Ettinger DS, et al. Among authors: aggarwal c. J Natl Compr Canc Netw. 2019 Dec;17(12):1464-1472. doi: 10.6004/jnccn.2019.0059. J Natl Compr Canc Netw. 2019. PMID: 31805526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220 results

Search Page